Sandip P. Patel, MD

Articles by Sandip P. Patel, MD

Overcoming Barriers to Widespread Neoadjuvant Lung Cancer Testing: Sandip Patel, MD

September 8th 2025

Disparities in lung cancer biomarker testing show barriers that delay diagnosis and treatment for lower-income patients, according to Sandip P. Patel, MD.

Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations

ByMark Socinski, MD,John Heymach, MD, PhD,Wade Iams, MD,Sandip P. Patel, MD

August 19th 2024

The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.

Overcoming Immunotherapy Resistance: Identifying Non-Responders and Novel Approaches

ByMark Socinski, MD,John Heymach, MD, PhD,Wade Iams, MD,Sandip P. Patel, MD

August 12th 2024

The panel shares clinical practices for overcoming immunotherapy resistance in patients with non-small cell lung cancer.

Clinical Factors Impacting Immunotherapy Response and Optimizing Patient Selection

ByMark Socinski, MD,John Heymach, MD, PhD,Wade Iams, MD,Sandip P. Patel, MD

August 12th 2024

A panel of experts on non-small cell lung cancer outline factors that impact how well patients respond to immunotherapy.

Sandip P. Patel, MD

Articles by Sandip P. Patel, MD

Overcoming Barriers to Widespread Neoadjuvant Lung Cancer Testing: Sandip Patel, MD

Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations

Overcoming Immunotherapy Resistance: Identifying Non-Responders and Novel Approaches

Clinical Factors Impacting Immunotherapy Response and Optimizing Patient Selection

Latest Updated Articles

Trending on AJMC

Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer

New Biomarkers, Drug Targets Identified for Colorectal Cancer

First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC

Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal

Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability